The association between gut hormones and diet-induced metabolic flexibility in metabolically healthy adults.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
01 2023
Historique:
revised: 11 08 2022
received: 12 05 2022
accepted: 15 08 2022
pmc-release: 01 01 2024
pubmed: 7 12 2022
medline: 23 12 2022
entrez: 6 12 2022
Statut: ppublish

Résumé

This study investigated whether interindividual variance in diet-induced metabolic flexibility is explained by differences in gut hormone concentrations. A total of 69 healthy volunteers with normal glucose regulation underwent 24-hour assessments of respiratory quotient (RQ) in a whole-room indirect calorimeter during eucaloric feeding (EBL; 50% carbohydrate, 30% fat) and then, in a crossover design, during 24-hour fasting and three normal-protein (20%) overfeeding diets (200% energy requirements). Metabolic flexibility was defined as the change in 24-hour RQ from EBL during standard (50% carbohydrate), high-fat (60%), and high-carbohydrate (75%) overfeeding diets. Plasma concentrations of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) after an overnight fast were measured prior to and after each diet. Compared with EBL, on average, 24-hour RQ decreased by ~4% during high-fat overfeeding, whereas it increased by ~4% during standard overfeeding and by ~9% during high-carbohydrate overfeeding. During high-carbohydrate overfeeding, but not during any other overfeeding diet or fasting, increased GLP-1 concentration was associated with increased RQ (r = 0.44, p < 0.001), higher/lower carbohydrate/lipid oxidation rates (r = 0.34 and r = -0.51, both p < 0.01), respectively, and increased plasma insulin concentration (r = 0.38, p = 0.02). Increased GLP-1 concentration following high-carbohydrate overfeeding associated with a greater shift to carbohydrate oxidation, suggesting that GLP-1 may be implicated in diet-induced metabolic flexibility to carbohydrate overload.

Identifiants

pubmed: 36471908
doi: 10.1002/oby.23584
pmc: PMC9780166
mid: NIHMS1835207
doi:

Substances chimiques

Carbohydrates 0
Gastrointestinal Hormones 0
Glucagon-Like Peptide 1 89750-14-1
Insulin 0

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-149

Subventions

Organisme : Intramural NIH HHS
ID : ZIA DK069029
Pays : United States

Informations de copyright

Published 2022. This article is a U.S. Government work and is in the public domain in the USA.

Références

Am J Physiol Regul Integr Comp Physiol. 2016 May 1;310(9):R866-74
pubmed: 26818056
Am J Physiol. 1990 Nov;259(5 Pt 1):E650-7
pubmed: 2240203
Am J Clin Nutr. 2006 Sep;84(3):556-60
pubmed: 16960169
Am J Clin Nutr. 1988 Apr;47(4):591-607
pubmed: 3281433
Int J Obes Relat Metab Disord. 2000 Mar;24(3):288-98
pubmed: 10757621
Endocrinology. 2006 Jan;147(1):3-8
pubmed: 16166213
Rev Endocr Metab Disord. 2014 Sep;15(3):181-7
pubmed: 24811133
Diabetes. 2004 Mar;53(3):654-62
pubmed: 14988249
Obesity (Silver Spring). 2006 Sep;14(9):1562-70
pubmed: 17030967
J Nutr. 2006 Jan;136(1):195-201
pubmed: 16365082
Endocr Rev. 2018 Aug 1;39(4):489-517
pubmed: 29697773
Endocrinology. 2010 Feb;151(2):569-75
pubmed: 19915164
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S109-19
pubmed: 19136979
Metabolism. 2019 Jul;96:46-55
pubmed: 31029770
PLoS One. 2018 Jan 31;13(1):e0191609
pubmed: 29385178
Obesity (Silver Spring). 2017 May;25(5):873-880
pubmed: 28440048
Endocrinology. 2005 Dec;146(12):5120-7
pubmed: 16150917
Diabetes. 2020 Feb;69(2):181-192
pubmed: 31712321
Obesity (Silver Spring). 2020 Nov;28(11):2073-2077
pubmed: 32985108
Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1248-56
pubmed: 24735885
Diabetes. 2002 Dec;51 Suppl 3:S434-42
pubmed: 12475787
Int J Pediatr Endocrinol. 2009;2009:141753
pubmed: 19946401
J Physiol. 2009 Jan 15;587(1):19-25
pubmed: 19064614
Nutr Metab (Lond). 2016 Dec 9;13:92
pubmed: 27990172
Obesity (Silver Spring). 2019 May;27(5):691-699
pubmed: 31012296
Obesity (Silver Spring). 2020 Jun;28(6):1110-1116
pubmed: 32369268
Peptides. 1998;19(5):869-75
pubmed: 9663452
Cell Metab. 2017 May 2;25(5):1027-1036
pubmed: 28467922
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1009-17
pubmed: 18765680
Int J Obes Relat Metab Disord. 2001 Jun;25(6):781-92
pubmed: 11439290
Nature. 2002 Aug 8;418(6898):650-4
pubmed: 12167864
Diabetes Care. 2003 Jan;26 Suppl 1:S5-20
pubmed: 12502614
Int J Obes (Lond). 2017 Jun;41(6):887-893
pubmed: 28262678
Diabetologia. 1986 Jan;29(1):46-52
pubmed: 3514343
Diabetes Res Clin Pract. 2018 Aug;142:222-235
pubmed: 29857094
Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1062-8
pubmed: 17148749
Clin Sci (Lond). 1999 Apr;96(4):335-42
pubmed: 10087239
Obesity (Silver Spring). 2013 Aug;21(8):1602-7
pubmed: 23666746
Am J Physiol. 1988 Sep;255(3 Pt 1):E332-7
pubmed: 3421330
Diabetes. 2015 Nov;64(11):3680-9
pubmed: 26185280
Curr Obes Rep. 2018 Dec;7(4):276-288
pubmed: 30155850
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E238-45
pubmed: 16940471
J Clin Endocrinol Metab. 2013 Jul;98(7):2791-9
pubmed: 23666976
J Clin Endocrinol Metab. 2013 May;98(5):E847-55
pubmed: 23509106

Auteurs

Yigit Unlu (Y)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.

Karyne L Vinales (KL)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.
Endocrinology Division, Medicine Department, Phoenix VA Health Care System, Phoenix, Arizona, USA.

Tim Hollstein (T)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.
Division of Endocrinology, Diabetology and Clinical Nutrition, Department of Internal Medicine 1, University of Kiel, Kiel, Germany.

Douglas Chang (D)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.

Tomás Cabeza de Baca (T)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.

Mary Walter (M)

Clinical Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Jonathan Krakoff (J)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.

Paolo Piaggi (P)

Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, USA.
Department of Information Engineering, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH